In our latest Clarity Clinic interview, we ask Reinhilde Weidacher of ISS Ethix, what she considers the biggest change in sustainable investing in a decade and which issues are dominating investor discussions today?
Aviva Investors is urging pharmaceutical companies to consider the threat to their business models posed by antibiotic resistance through a series of meetings and sharing examples of best practice.
Aviva Investors is urging pharmaceutical companies to consider the threat to their business models posed by antibiotic resistance through a series of meetings and sharing examples of best practice.
